Quick Answer
ACTUATE THERAPEUTICS, INC. reported Stockholders Equity of $7.92 million for fiscal year 2025.
ACTUATE THERAPEUTICS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $7.92M | +7505.6% |
| 2024 | $104.2K | +100.1% |
| 2023 | -$99.63M | -32.3% |
| 2022 | -$75.31M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $10.94M | +104.1% | +512.1% |
| June 30, 2025 | -$2.65M | +97.7% | +47.8% |
| March 31, 2025 | -$5.09M | +95.3% | -4983.3% |
| December 31, 2024 | $104.2K | +100.1% | -98.1% |
| September 30, 2024 | $5.36M | +105.8% | +104.7% |
| June 30, 2024 | -$114.26M | -32.9% | -6.0% |
| March 31, 2024 | -$107.77M | -33.9% | -8.2% |
| December 31, 2023 | -$99.63M | -32.3% | -8.1% |
- ACTUATE THERAPEUTICS, INC. showed an increase of +7505.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2022–2025 period, ACTUATE THERAPEUTICS, INC.’s stockholders equity has grown by 110.5% (from -$75.31 million to $7.92 million).
- The most recent figure is from ACTUATE THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: